Among these, ABCC3, ACPP, PPP1CA, PRKAG3, and RNASEL exhibited interactions with several proteins, immune checkpoint markers, and chemotherapeutic drugs administered in both human breast cancer and FMC (Fig 5). This evidence concerns the gene ACP3 and breast carcinoma.